THQ News and Press, Tekla Healthcare Opportunies Fund Shares of Beneficial Interest From 07/16/22

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promises high distributions and reasonable total returns. Closed-end funds are generally characterized by higher volatility and deeper drawdowns than the broad marke...

We are closing the chapter on another volatile quarter for the market, a downtrend that feels like forever. There could be more opportunities in the coming months and quarters as the Fed continues to raise rates. Despite this, I buy every month to grow my income over time - 2022 h...

THQ had joined the rest of the CEF space in premium territory in 2021. This was yet another fund that had never traded at a premium previously. THQ's distribution yield is sustainable as the NAV yield is reasonable and healthcare remains a defensive sector. Written by ...

We previously discussed Buffett's explanation for why smart people go broke. We then made the connection to why we generally don't buy CEFs. However, this does not mean that investors should never buy any CEFs under any circumstances. Back in March, we wrote : ...

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promises high distributions and reasonable total returns. Closed-end funds are generally characterized by higher volatility and deeper drawdowns than the broad marke...

Tekla Healthcare Opportunities Fund (NYSE:THQ) has declared $0.1125/share monthly dividend, in line with previous. Payable May 31; for shareholders of record May 20; ex-div May 19. See THQ Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Tekla Health...

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promise high distributions and reasonable total returns. Closed-end funds are generally characterized by higher volatility and deeper drawdowns than the broad market...

GRX’s total return has been negative, and yield has been quite average over the short term. GRX failed to record double digit average total return over the medium and long term. GRX has a quite high expense ratio and doesn’t have significant investments in any one st...

THW is a rare healthcare fund that performed well in April 2022 as well as in past 3 months and 3 years. THW is relatively better protected from market risk due to exposure in global equity markets. THW’s stock selection is impressive, and top investments generated high pos...

HQL pays regular quarterly dividends with a close to double digit yield, and despite poor price growth over medium and long run, HQL’s total return is impressive. In the past three months, a dividend cut and extension of buyback period played a significant role in price movemen...